Atomo Diagnostics Limited (ASX:AT1)
0.0290
+0.0020 (7.41%)
Nov 14, 2025, 3:16 PM AEST
Atomo Diagnostics Revenue
In the fiscal year ending June 30, 2025, Atomo Diagnostics had annual revenue of 3.79M AUD, down -7.20%. Atomo Diagnostics had revenue of 1.74M in the half year ending June 30, 2025, with 46.86% growth.
Revenue
3.79M
Revenue Growth
-7.20%
P/S Ratio
6.20
Revenue / Employee
44.62K
Employees
85
Market Cap
23.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.79M | -294.18K | -7.20% |
| Jun 30, 2024 | 4.09M | 1.54M | 60.65% |
| Jun 30, 2023 | 2.54M | -9.79M | -79.38% |
| Jun 30, 2022 | 12.34M | 5.62M | 83.69% |
| Jun 30, 2021 | 6.72M | 1.35M | 25.09% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |
Atomo Diagnostics News
- 2 months ago - Atomo Diagnostics Ltd (ASX:AT1) Full Year 2025 Earnings Call Highlights: Navigating Challenges ... - GuruFocus